SpringerProtocols: Abstract: Derivation and Propagation of Embryonic Stem Cells in Serum- and Feeder-Free Culture

Derivation and Propagation of Embryonic Stem Cells in Serum- and Feeder-Free Culture

By: Jennifer Nichols², Qi-Long Ying³

Abstract

Full Text

Download PDF (793K)

The availability of murine embryonic stem (ES) cells has revolutionized the study of mammalian development and disease. We recently developed a culture medium that has enabled us to identify the essential signaling pathways required for maintenance of pluripotency in vitro. Addition of leukemia inhibitory factor and bone morphogenetic protein4 to this medium is sufficient to activate the signal transducer and activator of transcription3 and mammalian homolog of Drosophila mothers against decapentaplegic pathways, respectively. We have successfully derived and propagated ES cells in the absence of feeder cells and serum. This chapter describes a simple protocol for efficient derivation and maintenance of ES cells from embryos of the 129 and C57Bl/6 strains of mice.

Affiliation(s): (2) Centre Development in Stem Cell Biology, Institute for Stem Cell Research, University of Edinburgh, Edinburgh, UK
(3) Centre Development in Stem Cell Biology, Institute for Stem Cell Research, University of Edinburgh, Edinburgh, UK

Book Title: Embryonic Stem Cell Protocols: Volume 1: Isolation and Characterization

Series: Methods in Molecular Biology | Volume: 329 | Pub. Date: Feb-15-2006 | Page Range: 91-98 | DOI: 10.1385/1-59745-037-5:91

Subject: Cell Biology

Key Words: BMP - diapause/delayed implantation - ES cell derivation - gp130 - Id - LIF - pluripotency - SMAD - STAT3

References

Download References

1.	Williams R. L., Hilton D. J., Pease S., et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684–687.

2.	Robertson E. J. (1987) Teratocarcinoma and Embryo-Derived Stem Cells: A Practical Approach, IRL Press, Oxford, UK.

3.	Kawase E., Suemori H., Takahashi N., Okazaki K., Hashimoto K., and Nakatsuji N. (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38, 385–390.

4.	Hunter S. and Evans M. (1999) Non-surgical method for the induction of delayed implantation and recovery of viable blastocysts in rats and mice by the use of tamoxifen and Depo-Provera. Mol. Reprod. Dev. 52, 29–32. <Occurrence Type="DOI"><Handle>10.1002/(SICI)1098-2795(199901)52:1<29::AID-MRD4>3.0.CO;2-2</Handle></Occurrence>

5.	Nichols J., Chambers I., Taga T., and Smith A. (2001) Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128, 2333–2339.

6.	Buehr M. and Smith A. (2003) Genesis of embryonic stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358, 1397–402, discussion 1402.

7.	Burdon T., Stracey C., Chambers I., Nichols J., and Smith A. (1999) Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30–43.

8.	Brook F. A. and Gardner R. L. (1997) The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94, 5709–5712.

9.	Ying Q.-L., Nichols J., Chambers I., and Smith A. (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281–292. <Occurrence Type="DOI"><Handle>10.1016/S0092-8674(03)00847-X</Handle></Occurrence>

10.	Nichols J., Chambers I., and Smith A. (1994) Derivation of germline competent embryonic stem cells with combination of interleukin-6 and soluble interleukin-6 receptor. Exp. Cell Res. 215, 237–239.

11.	Evans M. J. and Kaufman M. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156.

12.	Martin G. R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634–7638.

13.	Moreau J. F., Donaldson D. D., Bennett F., Witek-Giannotti J., Clark S. C., and Wong G. G. (1988) Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336, 690–692.

14.	Smith A. G., Heath J. K., Donaldson D. D., et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688–690.

15.	Seong E., Saunders T. L., Stewart C. L., and Burmeister M. (2004) To knockout in 129 or in C57BL/6: that is the question. Trends Genet. 20, 59–62.

16.	Nichols J., Evans E. P., and Smith A. G. (1990) Establishment of germ-line competent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110, 1341–1348.

17.	Pease S., Braghetta P., Gearing D., Grail D., and Williams R. L. (1990) Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev. Biol. 141, 344–352. <Occurrence Type="DOI"><Handle>10.1016/0012-1606(90)90390-5</Handle></Occurrence>

18.	Buehr M., Nichols J., Stenhouse F., et al. (2003) Rapid loss of Oct-4 and pluripotency in cultured rodent blastocysts and derivative cell lines. Biol. Reprod. 68, 222–229.

19.	Hogan B., Beddington R., Costantini F., and Lacy E. (1994) Manipulating the Mouse Embryo: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 497.

Comments (Loading...)

Post comment/View all comments